tiprankstipranks
Advertisement
Advertisement
Bioventus Affirms Outlook After FDA Device Reclassification
PremiumCompany AnnouncementsBioventus Affirms Outlook After FDA Device Reclassification
2M ago
Bioventus Reiterated at Buy as Strong FY26 Start, Deleveraging, and Discount Valuation Support Unchanged $15 Price Target
Premium
Ratings
Bioventus Reiterated at Buy as Strong FY26 Start, Deleveraging, and Discount Valuation Support Unchanged $15 Price Target
2M ago
Bioventus reports Q1 EPS 15c, consensus 7c
Premium
The Fly
Bioventus reports Q1 EPS 15c, consensus 7c
2M ago
Bioventus management to meet with Barrington
PremiumThe FlyBioventus management to meet with Barrington
4M ago
Bioventus price target raised to $16 from $15 at Craig-Hallum
Premium
The Fly
Bioventus price target raised to $16 from $15 at Craig-Hallum
4M ago
Bioventus price target raised to $14 from $13 at Barrington
Premium
The Fly
Bioventus price target raised to $14 from $13 at Barrington
4M ago
Bioventus Appoints Ajay Dhankhar as New Director
PremiumCompany AnnouncementsBioventus Appoints Ajay Dhankhar as New Director
8M ago
Bioventus Reports Strong Q3 2025 Financial Performance
Premium
Company Announcements
Bioventus Reports Strong Q3 2025 Financial Performance
8M ago
Bioventus, Inc. Reports Strong Q3 Earnings Growth
Premium
Company Announcements
Bioventus, Inc. Reports Strong Q3 Earnings Growth
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100